All lobbying filings
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) filed a Q3 report for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) on October 20, 2026.
Lobbying for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$2,650,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Government bodies contacted
6
Lobbying activity
5
Issues related to prior authorization.
Issues related to PBM and drug pricing reform, health care transparency and affordability. P.L. 119-75 Consolidated Appropriations Act, 2026. Issues related to the specialty drug market.
Issues related to Tricare pharmacy issues.
Issues related to health plan and PBM transparency, employer sponsored health insurance. Issues related to the No Surprises Act.
Issues related to competition in the health care marketplace.